Pfizer and BioNTech will begin manufacturing their Covid-19 vaccine in South Africa, as part of an effort to accelerate the rollout of the jab on a continent battling another wave of infections.
The US pharma group and German biotech, who together created the first mRNA-based Covid vaccine to win regulatory approval, said on Wednesday that they would work with the Biovac Institute in Cape Town.
The collaboration with Biovac will enable its facility in Cape Town to complete the final stages of production, known as “fill and finish”, while still importing the vaccine material from Europe.
您已閱讀22%（591字），剩餘78%（2047字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。